Piper Sandler raised the firm’s price target on Fulgent Genetics (FLGT) to $30 from $21 and keeps a Neutral rating on the shares. The firm cites the company’s quarterly results for the price target change.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FLGT: